Author:
Carrasco-Garrido Pilar,de Miguel-Díez Javier,Rejas-Gutierrez Javier,Martín-Centeno Antonio,Gobartt-Vázquez Elena,Hernandez-Barrera Valentin,de Miguel Angel Gil,Jimenez-Garcia Rodrigo
Abstract
Abstract
Background
The objective of this study was to analyze the clinical and management characteristics of chronic obstructive pulmonary disease (COPD) in men and women, to determine possible gender-associated differences between the two groups of patients.
Methods
An observational and descriptive epidemiological study (EPIDEPOC study). The study included patients with stable COPD and aged ≥ 40 years, evaluated in primary care. Data were collected relating to sociodemographic variables, clinical characteristics, quality of life (SF-12), severity of disease and treatment. The results obtained in men and women were compared.
Results
A total of 10,711 patients (75.6% males and 24.4% females) were evaluated. Significant differences were found between males and females in relation to the following parameters: age (67.4 ± 9.2 years in men vs 66.1 ± 10.8 in women, p < 0.05), smoking (91.9% of the men were smokers or ex-smokers vs 30% of the women), comorbidity (the frequency of hypertension, diabetes, anxiety and depression was greater in women, while ischemic heart disease was more common in men), mental component of quality of life (49.4 ± 10.3 in men vs 44.6 ± 11.9 in women, p < 0.05) and severity of disease (56.5 ± 13.3% in men vs 60.7 ± 3.2 in women, p < 0.05). As regards treatment, the percentage use of long-acting b2-adrenergic agonists, anticholinergic agents, theophyllines and mucolytic agents was significant greater in men. The total annual cost of COPD was greater in males than in females (1989.20 ± 2364.47 € vs 1724.53 ± 2106.90, p < 0.05).
Conclusion
The women with COPD evaluated in this study were younger, smoked less and have more comorbidity, a poorer quality of life, and lesser disease severity than men with COPD. However, they generated a lesser total annual cost of COPD than men.
Publisher
Springer Science and Business Media LLC
Subject
Pulmonary and Respiratory Medicine
Reference52 articles.
1. Soriano JB, Maier WC, Egger P, Visick G, Thakrar B, Sykes J, Pride NB: Recent trends in physician diagnosed COPD in women and men in the UK. Thorax. 2000, 55: 789-794. 10.1136/thorax.55.9.789.
2. Ulrik CS: Smoking and mortality in women: "smoke like a man, die (at least) like a man". Respiratory Disease in Women. Eur Respir Mon. Edited by: Buist S, Mapp CE, Rossi A. 2003, 25: 103-117.
3. Mannino DM, Homa DM, Akinbami LJ, Ford ES, Redd SC: Chronic obstructive pulmonary disease surveillance-United States, 1971–2000. MMWR Surveill Summ. 2002, 51 (6): 1-16.
4. Lacasse Y, Brooks D, Goldstein RS: Trends in the epidemiology of COPD in Canada, 1980 to 1995. COPD and rehabilitation committee of the Canadian Thoracic Society. Chest. 1999, 116: 306-313. 10.1378/chest.116.2.306.
5. Keistinen T, Vilkman S, Tuuponen T, Kivela SL: Hospital admissions for chronic obstructive pulmonary disease in the population aged 55 years or over in Finland during 1972–1992. Public Health. 1996, 110: 257-259. 10.1016/S0033-3506(96)80113-2.